{"id":"https://openalex.org/W3000708283","doi":"https://doi.org/10.1007/s40123-020-00229-x","title":"Ocular and Systemic Pharmacokinetics of Brimonidine and Timolol After Topical Administration in Rabbits: Comparison Between Fixed-Combination and Single Drugs","display_name":"Ocular and Systemic Pharmacokinetics of Brimonidine and Timolol After Topical Administration in Rabbits: Comparison Between Fixed-Combination and Single Drugs","publication_year":2020,"publication_date":"2020-01-17","ids":{"openalex":"https://openalex.org/W3000708283","doi":"https://doi.org/10.1007/s40123-020-00229-x","mag":"3000708283","pmid":"https://pubmed.ncbi.nlm.nih.gov/31953739","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7054494"},"language":"en","primary_location":{"id":"doi:10.1007/s40123-020-00229-x","doi":"https://doi.org/10.1007/s40123-020-00229-x","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40123-020-00229-x","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40123-020-00229-x.pdf","source":{"id":"https://openalex.org/S2764742808","display_name":"Ophthalmology and Therapy","issn_l":"2193-8245","issn":["2193-8245","2193-6528"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ophthalmology and Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://link.springer.com/content/pdf/10.1007/s40123-020-00229-x.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045666257","display_name":"Gen Suzuki","orcid":"https://orcid.org/0000-0002-1911-971X","observed_orcids":["https://orcid.org/0000-0002-1911-971X"]},"institutions":[{"id":"https://openalex.org/I4210133062","display_name":"Senju Pharmaceutical (Japan)","ror":"https://ror.org/03hq4qb06","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210133062"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Gen Suzuki","raw_affiliation_strings":["Research and Development Division, Senju Pharmaceutical Co., Ltd., Osaka, Japan. gen-suzuki@senju.co.jp","Research and Development Division, Senju Pharmaceutical Co., Ltd., Osaka, Japan"],"raw_orcid":"https://orcid.org/0000-0002-1911-971X","affiliations":[{"raw_affiliation_string":"Research and Development Division, Senju Pharmaceutical Co., Ltd., Osaka, Japan. gen-suzuki@senju.co.jp","institution_ids":["https://openalex.org/I4210133062"]},{"raw_affiliation_string":"Research and Development Division, Senju Pharmaceutical Co., Ltd., Osaka, Japan","institution_ids":["https://openalex.org/I4210133062"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011551992","display_name":"Eriko Kunikane","orcid":"https://orcid.org/0000-0002-4742-9459","observed_orcids":["https://orcid.org/0000-0002-4742-9459"]},"institutions":[{"id":"https://openalex.org/I4210133062","display_name":"Senju Pharmaceutical (Japan)","ror":"https://ror.org/03hq4qb06","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210133062"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Eriko Kunikane","raw_affiliation_strings":["Research and Development Division, Senju Pharmaceutical Co., Ltd., Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development Division, Senju Pharmaceutical Co., Ltd., Osaka, Japan","institution_ids":["https://openalex.org/I4210133062"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074678513","display_name":"Keisuke Shinno","orcid":"https://orcid.org/0000-0002-9685-8962","observed_orcids":["https://orcid.org/0000-0002-9685-8962"]},"institutions":[{"id":"https://openalex.org/I4210133062","display_name":"Senju Pharmaceutical (Japan)","ror":"https://ror.org/03hq4qb06","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210133062"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Keisuke Shinno","raw_affiliation_strings":["Research and Development Division, Senju Pharmaceutical Co., Ltd., Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development Division, Senju Pharmaceutical Co., Ltd., Osaka, Japan","institution_ids":["https://openalex.org/I4210133062"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022036061","display_name":"Seiko Kozai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133062","display_name":"Senju Pharmaceutical (Japan)","ror":"https://ror.org/03hq4qb06","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210133062"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Seiko Kozai","raw_affiliation_strings":["Research and Development Division, Senju Pharmaceutical Co., Ltd., Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development Division, Senju Pharmaceutical Co., Ltd., Osaka, Japan","institution_ids":["https://openalex.org/I4210133062"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101610088","display_name":"Masaaki Kurata","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133062","display_name":"Senju Pharmaceutical (Japan)","ror":"https://ror.org/03hq4qb06","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210133062"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masaaki Kurata","raw_affiliation_strings":["Research and Development Division, Senju Pharmaceutical Co., Ltd., Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development Division, Senju Pharmaceutical Co., Ltd., Osaka, Japan","institution_ids":["https://openalex.org/I4210133062"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5054696863","display_name":"Akio Kawamura","orcid":"https://orcid.org/0000-0003-3482-8853","observed_orcids":["https://orcid.org/0000-0003-3482-8853"]},"institutions":[{"id":"https://openalex.org/I4210133062","display_name":"Senju Pharmaceutical (Japan)","ror":"https://ror.org/03hq4qb06","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210133062"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Akio Kawamura","raw_affiliation_strings":["Research and Development Division, Senju Pharmaceutical Co., Ltd., Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development Division, Senju Pharmaceutical Co., Ltd., Osaka, Japan","institution_ids":["https://openalex.org/I4210133062"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5045666257"],"corresponding_institution_ids":["https://openalex.org/I4210133062"],"apc_list":{"value":5100,"currency":"USD","value_usd":5100},"apc_paid":{"value":5100,"currency":"USD","value_usd":5100},"fwci":4.1916,"has_fulltext":true,"cited_by_count":28,"citation_normalized_percentile":{"value":0.9511997,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"9","issue":"1","first_page":"115","last_page":"125"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10250","display_name":"Glaucoma and retinal disorders","score":0.6342999935150146,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10250","display_name":"Glaucoma and retinal disorders","score":0.6342999935150146,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.11919999867677689,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.07069999724626541,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/brimonidine","display_name":"brimonidine","score":0.9549999833106995},{"id":"https://openalex.org/keywords/timolol","display_name":"timolol","score":1.0},{"id":"https://openalex.org/keywords/ocular-pharmacokinetics","display_name":"ocular pharmacokinetics","score":0.8740000128746033},{"id":"https://openalex.org/keywords/systemic-pharmacokinetics","display_name":"systemic pharmacokinetics","score":0.9340000152587891},{"id":"https://openalex.org/keywords/topical-ocular-administration","display_name":"topical ocular administration","score":0.7509999871253967},{"id":"https://openalex.org/keywords/aqueous-humor","display_name":"aqueous humor","score":0.7149999737739563},{"id":"https://openalex.org/keywords/vitreous-body","display_name":"vitreous humor","score":0.8100000023841858},{"id":"https://openalex.org/keywords/plasma-drug-concentration","display_name":"plasma drug concentration","score":0.5699999928474426},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.7289999723434448},{"id":"https://openalex.org/keywords/brimonidine-tartrate","display_name":"brimonidine tartrate","score":0.7739999890327454}],"concepts":[{"id":"https://openalex.org/C2778190193","wikidata":"https://www.wikidata.org/wiki/Q577377","display_name":"Brimonidine","level":3,"score":0.960343599319458},{"id":"https://openalex.org/C2778073030","wikidata":"https://www.wikidata.org/wiki/Q413994","display_name":"Timolol","level":3,"score":0.9460744857788086},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6536568999290466},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.6338784694671631},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5521572232246399},{"id":"https://openalex.org/C2776727336","wikidata":"https://www.wikidata.org/wiki/Q415401","display_name":"Dorzolamide","level":4,"score":0.49130502343177795},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.47432583570480347},{"id":"https://openalex.org/C2777625524","wikidata":"https://www.wikidata.org/wiki/Q552308","display_name":"Eye drop","level":2,"score":0.43028366565704346},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3801884353160858},{"id":"https://openalex.org/C2781092963","wikidata":"https://www.wikidata.org/wiki/Q650050","display_name":"Intraocular pressure","level":2,"score":0.3787900507450104},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.32489460706710815},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.13349944353103638}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1007/s40123-020-00229-x","doi":"https://doi.org/10.1007/s40123-020-00229-x","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40123-020-00229-x","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40123-020-00229-x.pdf","source":{"id":"https://openalex.org/S2764742808","display_name":"Ophthalmology and Therapy","issn_l":"2193-8245","issn":["2193-8245","2193-6528"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ophthalmology and Therapy","raw_type":"journal-article"},{"id":"pmid:31953739","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31953739","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ophthalmology and therapy","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7054494","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7054494/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ophthalmol Ther","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:ca8e17d2d2814c93accf14397434a086","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/ca8e17d2d2814c93accf14397434a086","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Ophthalmology and Therapy, Vol 9, Iss 1, Pp 115-125 (2020)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1007/s40123-020-00229-x","doi":"https://doi.org/10.1007/s40123-020-00229-x","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40123-020-00229-x","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40123-020-00229-x.pdf","source":{"id":"https://openalex.org/S2764742808","display_name":"Ophthalmology and Therapy","issn_l":"2193-8245","issn":["2193-8245","2193-6528"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ophthalmology and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3000708283.pdf","grobid_xml":"https://content.openalex.org/works/W3000708283.grobid-xml"},"referenced_works_count":33,"referenced_works":["https://openalex.org/W1512461245","https://openalex.org/W1552424205","https://openalex.org/W1566290527","https://openalex.org/W1601920992","https://openalex.org/W1944278416","https://openalex.org/W1973679933","https://openalex.org/W1978664333","https://openalex.org/W1996174132","https://openalex.org/W2002983856","https://openalex.org/W2004725033","https://openalex.org/W2009565860","https://openalex.org/W2012624430","https://openalex.org/W2014785256","https://openalex.org/W2015733557","https://openalex.org/W2026975672","https://openalex.org/W2034742711","https://openalex.org/W2045268760","https://openalex.org/W2048231451","https://openalex.org/W2070086483","https://openalex.org/W2078860221","https://openalex.org/W2086791741","https://openalex.org/W2087041915","https://openalex.org/W2091438178","https://openalex.org/W2093858516","https://openalex.org/W2104838039","https://openalex.org/W2140594570","https://openalex.org/W2152544179","https://openalex.org/W2153472908","https://openalex.org/W2550427201","https://openalex.org/W2564173629","https://openalex.org/W2792534256","https://openalex.org/W2952450462","https://openalex.org/W4320507048"],"related_works":["https://openalex.org/W3044174223","https://openalex.org/W4310530576","https://openalex.org/W2128115703","https://openalex.org/W2127732920","https://openalex.org/W2991920775","https://openalex.org/W95931564","https://openalex.org/W2157872426","https://openalex.org/W2256912528","https://openalex.org/W2164696821","https://openalex.org/W1540054855"],"abstract_inverted_index":{"INTRODUCTION:":[0],"This":[1,285],"study":[2],"was":[3,78,142,156,186,233],"aimed":[4],"to":[5,21,133,144,266],"compare":[6],"ocular":[7,205,243,256],"tissue":[8],"distribution":[9],"and":[10,15,31,34,95,105,179,244,257,297],"systemic":[11,245,258],"exposure":[12],"of":[13,23,27,50,62,69,121,140,154,172,184,198,239,260,274,282,295],"brimonidine":[14,29,38,76,141,148,173,199,252,296],"timolol":[16,33,44,82,96,155,163,185],"after":[17,80,128,135,146,161,188,192],"single":[18,35,51,59,70],"topical":[19,60],"administration":[20,49,61,68,130,190,222,276,281],"rabbits":[22],"fixed-combination":[24,129,178,189],"ophthalmic":[25,40,45,64,249],"solution":[26,41,65],"0.1%":[28,75,147],"tartrate":[30,39,77,149],"0.5%":[32,43,81,162],"drugs":[36,123],"(0.1%":[37],"or":[42,47,66,90],"solution)":[46],"concomitant":[48,67,73,136,211,280],"drugs.":[52,71,284],"METHODS:":[53],"Rabbits":[54],"were":[55,107,131,200,224],"treated":[56],"with":[57,91,109,228],"a":[58,292],"each":[63],"For":[72,210],"administration,":[74,150,212],"administered":[79],"instillation":[83],"successively":[84],"within":[85],"10":[86],"s":[87],"(without":[88],"interval)":[89],"5-min":[92,229],"intervals.":[93,230],"Brimonidine":[94],"concentrations":[97,215],"in":[98,124,202,207,216,236,278],"the":[99,118,125,152,169,203,217,237,248,255,272,279],"aqueous":[100,126,218],"humor,":[101],"retina/choroid,":[102],"vitreous":[103],"body,":[104],"plasma":[106,166],"determined":[108],"liquid":[110],"chromatography-tandem":[111],"mass":[112],"spectrometry.":[113],"RESULTS:":[114],"The":[115,138,165],"area":[116,167],"under":[117,168],"curve":[119,170],"values":[120],"both":[122,213],"humor":[127,219],"comparable":[132,143],"those":[134,227],"administration.":[137,164,194],"value":[139,153,171],"that":[145,160,183],"whereas":[151],"1.6-fold":[157],"higher":[158,187],"than":[159,191,226],"did":[174],"not":[175],"differ":[176],"between":[177],"single-drug":[180,193],"administrations,":[181],"but":[182,251],"Similar":[195],"concentration-time":[196],"curves":[197],"observed":[201],"posterior":[204],"tissues":[206],"all":[208],"groups.":[209],"drug":[214],"without":[220],"an":[221,275],"interval":[223,277],"lower":[225],"CONCLUSION:":[231],"There":[232],"no":[234],"difference":[235],"effect":[238],"formulation":[240],"compositions":[241],"on":[242],"pharmacokinetics":[246],"among":[247],"solutions,":[250],"may":[253],"alter":[254],"absorption":[259],"timolol,":[261],"which":[262],"is":[263],"possibly":[264],"due":[265],"its":[267],"pharmacologic":[268],"action.":[269],"We":[270],"demonstrated":[271],"importance":[273],"these":[283],"concern":[286],"could":[287],"be":[288],"avoided":[289],"by":[290],"using":[291],"fixed":[293],"combination":[294],"timolol.":[298]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":16},{"year":2020,"cited_by_count":2}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2020-01-23T00:00:00"}